Literature DB >> 20562801

Role of routine small intestinal biopsy in adult patient with irritable bowel syndrome-like symptoms.

A Pironti1, V Tadeu, A Pedroni, A Porcu, A Manca, G Massarelli, G Realdi, M P Dore.   

Abstract

AIM: The clinical evaluation of patients with chronic diarrhea and/or abdominal pain requires a complex work-up. The aim of the study was to evaluate whether routine duodenal biopsy sampling of macroscopically normal mucosa of patients with irritable bowel syndrome-like symptoms undergoing upper endoscopy assists in diagnosis and management.
METHODS: Consecutive adults scheduled for upper endoscopy for evaluation of uninvestigated dyspepsia and abdominal pain and/or chronic diarrhea based upon the history, were enrolled. Gastric biopsies and 3 duodenal biopsies were taken for histological evaluation.
RESULTS: A total of 786 sets of biopsies from 262 consecutive patients (200 females and 62 males, mean age 46 years; range: 15-82), were analyzed. Microscopic damage was observed in 212 of 262 patients (81%) with normal mucosa. Mild to moderate and severe duodenitis or villi atrophy was histologically confirmed in 65%, 26% and 8% of 212 patients respectively. The negative predictive value of a normal appearing duodenal mucosa was 19%. Additional tests confirmed celiac disease in 12 patients. Lactose malabsorption was present in 42%, bacterial overgrowth in 14%, and H. pylori infection in 28%. Colonoscopy performed in 92 patients revealed non specific colitis (25%), microscopic colitis (28%), Crohn's disease (1%), and diverticulosis (15%).
CONCLUSION: Duodenal biopsies revealed abnormalities in the majority of adults with chronic diarrhea and/or abdominal pain despite macroscopically normal gross findings. These results suggest that duodenal biopsies could be helpful in patients with chronic diarrhea and/or abdominal pain for the following work up.

Entities:  

Mesh:

Year:  2010        PMID: 20562801

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  7 in total

Review 1.  The role of eosinophils and mast cells in intestinal functional disease.

Authors:  Marjorie M Walker; Alasdair Warwick; Chuin Ung; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2011-08

2.  Utility of Analgesic and Anxiolytic Medication Dose during Colonoscopy in Identifying Patients with Irritable Bowel Syndrome.

Authors:  Enoch Lule; Erika Iddings; Lochana Manandhar; Bala Grandhi; John Clements
Journal:  ISRN Gastroenterol       Date:  2012-01-04

3.  Frequency of celiac disease in adult patients with typical or atypical malabsorption symptoms in isfahan, iran.

Authors:  Mohammad Hassan Emami; Soheila Kouhestani; Somayeh Karimi; Abdolmahdi Baghaei; Mohsen Janghorbani; Nahid Jamali; Ali Gholamrezaei
Journal:  Gastroenterol Res Pract       Date:  2012-04-01       Impact factor: 2.260

Review 4.  Routine disaccharidase testing: are we there yet?

Authors:  Antone R Opekun; Bruno P Chumpitazi; Mustafa M Abdulsada; Buford L Nichols
Journal:  Curr Opin Gastroenterol       Date:  2020-03       Impact factor: 2.741

5.  Unclear abdominal discomfort: pivotal role of carbohydrate malabsorption.

Authors:  Miriam Goebel-Stengel; Andreas Stengel; Marco Schmidtmann; Ivo van der Voort; Peter Kobelt; Hubert Mönnikes
Journal:  J Neurogastroenterol Motil       Date:  2014-04-30       Impact factor: 4.924

6.  Clinical and genetic profile of patients with seronegative coeliac disease: the natural history and response to gluten-free diet.

Authors:  Maria Pina Dore; Giovanni Mario Pes; Ivana Dettori; Vincenzo Villanacci; Alessandra Manca; Giuseppe Realdi
Journal:  BMJ Open Gastroenterol       Date:  2017-07-17

7.  Prevalence of Organic Colonic Lesions by Colonoscopy in Patients Fulfilling ROME IV Criteria of Irritable Bowel Syndrome.

Authors:  Mukesh Sharma Paudel; Amrendra Kumar Mandal; Barun Shrestha; Nandu Silwal Poudyal; Sudhamshu Kc; Sitaram Chaudhary; Ramila Shrestha; Khushboo Goel
Journal:  JNMA J Nepal Med Assoc       Date:  2018 Jan-Feb       Impact factor: 0.406

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.